Short-term Efficacy and Tolerability of Combination Therapy with Lovastatin and Acipimox in Chinese Patients with Type 2 Diabetes Mellitus and Mixed Dyslipidemia-Reference-Cited by-同舟云学术

Short-term Efficacy and Tolerability of Combination Therapy with Lovastatin and Acipimox in Chinese Patients with Type 2 Diabetes Mellitus and Mixed Dyslipidemia

Published:1998-10 Issue:10 Volume:38 Page:912-917
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Ko Gary T. C.,Mak Tony W. L.,Yeung Vincent T. F.,Chan Dick C. F.,Lam Christopher W. K.,Tsang Lynn W. W.,Chow Chun-Chung,Cockram Clive S.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. Management of dyslipidemia in type 2 diabetic;Garg;Diabetes Care,1990

2. Lipoprotein metabolism in diabetes mellitus;Howard;J Lipid Res,1987

3. Serum lipid profile and its association with some cardiovascular risk factors in an urban Chinese population;Lau;Pathology,1993

4. Selection of appropriate type and intensity of lipid-lowering therapy;Tikkanen;Curr Opin Lipidol,1995

5. Lovastatin for lowering cholesterol levels in noninsulin-dependent diabetes mellitus;Garg;N Engl J Med,1988

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in glucose metabolism, C-reactive protein, and liver enzymes following intake of NAD + precursor supplementation: a systematic review and meta‐regression analysis;Nutrition & Metabolism;2024-06-24

2. Adipose tissue: a regulator of inflammation;Best Practice & Research Clinical Endocrinology & Metabolism;2005-12

3. Current Lipid-lowering Strategies for the Treatment of Diabetic Dyslipidemia: An Integrated Approach to Therapy;The Endocrinologist;2001-09